Completed
Twinrix Pregnancy Registry
NCT03619590
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +15 more
- Locations
-
Not specified
Clinical trial condition
DNA Virus Infections
Explore clinical trials studying DNA Virus Infections. Study availability and eligibility vary by location and protocol.
3,920 public trials
503 recruiting studies
DNA Virus Infections trial results
NCT00127608
- Conditions
- Chickenpox, DNA Virus Infections, Herpesviridae Infections, +4 more
- Locations
-
- GSK Investigational Site Prague, Czechia
NCT01519570
- Conditions
- Chickenpox, DNA Virus Infections, Herpes Zoster Disease, +4 more
- Locations
-
- The Ohio State University Martha Morehouse General Internal Medicine Clinic Columbus, Ohio, United States
NCT01037114
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +12 more
- Locations
-
- GSK Investigational Site Ghent, Belgium
NCT02548325
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
- Locations
-
- Mútua de Terrassa Terrassa, Barcelona, Spain
Completed
Hepatitis B Vaccine for Non-responders
NCT03415672
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
- Locations
-
- Vaxinfectio - Antwerp University Antwerp, Belgium
- Ziekenhuis Oost-Limburg Genk, Belgium
- Maastricht UMC Maastricht, Netherlands
NCT02003703
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +9 more
- Locations
-
- Hospital Gustavo Fricke Viña del Mar, Valparaiso, Chile
Completed
Safety and Efficacy of Topical Cantharidin for the Treatment of Molluscum Contagiosum, Phase 2
NCT03017846
- Conditions
- DNA Virus Infections, Infections, Molluscum Contagiosum, +6 more
- Locations
-
- Montefiore Medical Center The Bronx, New York, United States
Completed
Treatment Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in naïve Chronic Hepatitis B
NCT02533544
- Conditions
- Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
- Locations
-
- The Catholic University of Korea, Daejeon St.Mary's Hosptial Junggu, Daejeon, South Korea
Completed
Alisertib and Romidepsin in Treating Patients With Relapsed or Refractory B-Cell or T-Cell Lymphomas
NCT01897012
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +36 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States